| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 706992 | Null | 0.022188614181866 | -0.22923786 |
| NSC 711077 | Null | 0.022188614181866 | 0.075138747 |
| NSC 716503 | Null | 0.022188614181866 | -0.035900366 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.022188614181866 | 0.51098603 |
| NSC 725098 | Null | 0.022188614181866 | 0.22461751 |
| NSC 726217 | Combretastatin A4-analogue | 0.022188614181866 | 0.18236399 |
| NSC 726578 | Null | 0.022188614181866 | 0.25402677 |
| NSC 741425 | 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide | 0.022188614181866 | 0.51669778 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.022188614181866 | 0.44789262 |
| NSC 743532 | Null | 0.022188614181866 | -0.082104646 |